DE69807454T2 - Kosmetische oder dermatologische verwendung von 7-hydroxylierten steroiden - Google Patents

Kosmetische oder dermatologische verwendung von 7-hydroxylierten steroiden

Info

Publication number
DE69807454T2
DE69807454T2 DE69807454T DE69807454T DE69807454T2 DE 69807454 T2 DE69807454 T2 DE 69807454T2 DE 69807454 T DE69807454 T DE 69807454T DE 69807454 T DE69807454 T DE 69807454T DE 69807454 T2 DE69807454 T2 DE 69807454T2
Authority
DE
Germany
Prior art keywords
carbon atoms
formula
dhea
hydroxy
hydrogen atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69807454T
Other languages
German (de)
English (en)
Other versions
DE69807454D1 (de
Inventor
Joseph Dray
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vitasterol Sarl
Original Assignee
Vitasterol Sarl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vitasterol Sarl filed Critical Vitasterol Sarl
Publication of DE69807454D1 publication Critical patent/DE69807454D1/de
Application granted granted Critical
Publication of DE69807454T2 publication Critical patent/DE69807454T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63Steroids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
DE69807454T 1997-03-10 1998-03-06 Kosmetische oder dermatologische verwendung von 7-hydroxylierten steroiden Expired - Fee Related DE69807454T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9702811A FR2760362B1 (fr) 1997-03-10 1997-03-10 Utilisation cosmetique ou dermatologique de steroides 7-hydroxyles
PCT/FR1998/000457 WO1998040074A1 (fr) 1997-03-10 1998-03-06 Utilisation cosmetique ou dermatologique de steroides 7-hydroxyles

Publications (2)

Publication Number Publication Date
DE69807454D1 DE69807454D1 (de) 2002-10-02
DE69807454T2 true DE69807454T2 (de) 2003-04-17

Family

ID=9504568

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69807454T Expired - Fee Related DE69807454T2 (de) 1997-03-10 1998-03-06 Kosmetische oder dermatologische verwendung von 7-hydroxylierten steroiden

Country Status (8)

Country Link
US (2) US6407084B2 (enExample)
EP (1) EP0973524B1 (enExample)
JP (1) JP2001515488A (enExample)
AU (1) AU6840298A (enExample)
DE (1) DE69807454T2 (enExample)
ES (1) ES2183341T3 (enExample)
FR (1) FR2760362B1 (enExample)
WO (1) WO1998040074A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0908183A1 (en) * 1997-10-08 1999-04-14 Institute For Advanced Skin Research Inc. Dehydroepiandrosterone or derivatives thereof for increasing the content of hyaluronic acid in skin
EP1054677B1 (en) * 1998-11-19 2008-10-22 Connective Tissue Imagineering LLC Cosmetic or dermatological use of 7-hydroxylated steroids alone and/or in combination with elastin derived peptides
FR2799645B1 (fr) * 1999-10-13 2004-04-30 Oreal Utilisation de la dhea ou de ses precurseurs ou derives metaboliques comme depigmentant
FR2803514B1 (fr) * 1999-10-13 2004-05-21 Oreal Compostion, notamment cosmetique, renfermant un steroide et un filtre uv liposoluble
GB0003524D0 (en) * 2000-02-15 2000-04-05 Btg Int Ltd Cytoprotective steroids (II)
GB2363983A (en) * 2000-06-29 2002-01-16 Hunter Fleming Ltd Protection against neuronal damage using 7-hydroxyepiandrosterone
FR2818135B1 (fr) 2000-12-15 2003-02-14 Oreal Composition, notamment cosmetique, renfermant la 7-hydroxy dhea et/ou la 7-ceto dhea et au moins un carotenoide
FR2818132B1 (fr) * 2000-12-15 2003-01-17 Oreal Utilisation de la 7-hydroxy dhea et/ou de la 7-ceto dhea pour traiter les desordres lies a une suractivite de la 5 alpha-reductase
FR2818148B1 (fr) 2000-12-15 2005-06-24 Oreal Composition,notamment cosmetique, renfermant, la 7-hydroxy dhea et/ou la 7-ceto dhea et au moins un isoflavonoide
FR2818149A1 (fr) * 2000-12-15 2002-06-21 Oreal Composition, notamment cosmetique, comprenant la 7-hydroxy dhea et/ou 7-ceto dhea et au moins un inhibiteur de 5 alpha-reductase
FR2827762A1 (fr) * 2001-07-24 2003-01-31 Oreal Utilisation de steroides comme amincissants
FR2828100B1 (fr) * 2001-08-02 2004-09-24 Galderma Res & Dev Composition de type emulsion inverse contenant de la dhea et/ou ses precurseurs ou derives, et ses utilisations en cosmetique et en dermatologie
FR2831440B1 (fr) * 2001-10-25 2003-12-26 Oreal Composition cosmetique, renfermant un derive de la dhea et un agent apaisant
FR2831441B1 (fr) 2001-10-25 2003-12-26 Oreal Utilisation cosmetique de derives de la dhea
US20020172647A1 (en) * 2002-03-06 2002-11-21 L'oreal Composition containing a steroid and a liposoluble UV filter
GB0403889D0 (en) * 2004-02-21 2004-03-24 Univ Edinburgh Uses of er-beta modulators
US8697152B2 (en) 2005-08-31 2014-04-15 Johnson & Johnson Consumer Companies, Inc. Anti-inflammatory compositions and personal care compositions comprising olive leaf (Olea europea) extract
US8758838B2 (en) 2005-08-31 2014-06-24 Johnson & Johnson Consumer Companies, Inc. Anti-inflammatory compositions and methods of use
SI1963280T1 (sl) 2005-12-22 2016-02-29 Newron Pharmaceuticals S.P.A. 2-feniletilamino derivati kot modulatorji kalcijevih in/ali natrijevih kanalčkov

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1076001B (it) * 1977-01-04 1985-04-22 Also Lab Di Dr P Sorbini & C S Composizione per il trattamento del cuoio capelluto e contro la caduta dei capelli
US4496556A (en) * 1982-08-16 1985-01-29 Norman Orentreich Topical applications for preventing dry skin
GB8417895D0 (en) * 1984-07-13 1984-08-15 Marples B A Pharmaceutical anti-fungal composition
US5019569A (en) * 1986-11-03 1991-05-28 Ortho Pharmaceutical Corporation Reversal of glucocorticoid-induced skin atrophy
US5461042A (en) * 1988-12-30 1995-10-24 Loria; Roger M. Regulation of the immune system
FR2696934B1 (fr) * 1992-10-20 1995-06-02 Conservatoire Nal Arts Metiers Dérivés de stéroïdes naturels 3B hydroxyles ayant des propriétés de déclenchement et de stimulation de l'immunité, composition les contenant et procédé pour les obtenir.
ZA947912B (en) * 1993-10-12 1995-05-24 Broadbent J W Nominees Pty Ltd Treatment of medical disorders associated with free radical formation
FR2729854A1 (fr) * 1995-01-26 1996-08-02 Oreal Utilisation du sulfate de dehydroepi-androsterone dans une composition cosmetique ou dermatologique
PL334840A1 (en) * 1997-01-24 2000-03-27 Univ California Application of fxr, pparalpha and lxralpha activators in order to restore the barrier function, to stimulate epithelium differentation and to inhibit proliferation

Also Published As

Publication number Publication date
AU6840298A (en) 1998-09-29
FR2760362A1 (fr) 1998-09-11
FR2760362B1 (fr) 2000-08-11
EP0973524B1 (fr) 2002-08-28
ES2183341T3 (es) 2003-03-16
EP0973524A1 (fr) 2000-01-26
US20010041696A1 (en) 2001-11-15
DE69807454D1 (de) 2002-10-02
US6620803B2 (en) 2003-09-16
US20020165214A1 (en) 2002-11-07
WO1998040074A1 (fr) 1998-09-17
US6407084B2 (en) 2002-06-18
JP2001515488A (ja) 2001-09-18

Similar Documents

Publication Publication Date Title
DE69807454T2 (de) Kosmetische oder dermatologische verwendung von 7-hydroxylierten steroiden
DE69516107T2 (de) Zusammensetzung, die die Apoptose moduliert und einen Faktor enthält, der den intrazellulären Gehalt an Methional oder Malondialdehyd beeinflusst
DE3621861A1 (de) Verwendung von aryloxycarbonsaeure-derivaten gegen dermatologische erkrankungen
DE69818806T2 (de) Antimikrobielle kosmetische präparate
DE1017748B (de) Praeparat zur Pflege der menschlichen Haut
DE3129867A1 (de) "ungesaettigte arylketone als antiseborrhoische zusaetze fuer kosmetische mittel"
DE69926881T2 (de) Zubereitungen zur aknebehandlung
DE60027434T2 (de) Petroselinsäure enthaltendes hautpflegemittel
DE2818586C2 (enExample)
DE69230069T2 (de) Steroide enthaltende zusammensetzungen zur anwendung am auge und ihre verwendung zur behandlung des glaukoms
EP0467116A1 (de) Dermatologische Zusammensetzungen mit einem Gehalt an cis-Urocaninsäure
DE3607651A1 (de) Kombination von aromatasehemmer und testosteron-5(alpha)-reduktase-hemmer
DE69433669T2 (de) Mittel für VERBESSERTE Durchblutung UND KOSMETISCHE MITTEL
EP0442350B1 (de) Arzneimittelzubereitung, enthaltend Stigmasta-4-en-3-on sowie deren Verwendung
DE69008293T2 (de) Synergistisches Mittel zur Hautdepigmentierung.
DE2757024C3 (de) Kosmetisches Haar- und Hautpflegemittel
DE2323615A1 (de) Zootechnische zusammensetzungen
AT205175B (enExample)
AT204183B (de) Verfahren zur Herstellung von Hautpflegemitteln mit regenerativer Wirkung
DE2604201A1 (de) Kosmetisches haarpflegemittel
DE1792778C3 (de) Mittel zur Behandlung von klimakterischen Beschwerden
DE1468919C (de) 3,11 Dioxo steroid 4,9 diene und ein Verfahren zu ihrer Herstellung
DE4001060C2 (enExample)
US20060292185A1 (en) Topical skin preparations for treatment of skin aging comprising a testosterone ester
EP0437694A1 (de) Verwendung einer Hydroxyoctadecadiensäure, deren zur Ketoform oxidierte Säure sowie deren Derivate zur Therapie östrogenabhängiger Krankheiten, sowie pharmazeutische Zusammensetzungen, die diese enthalten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee